T-Cypher Bio

T-Cypher Bio is a pre-clinical biotechnology company developing T-cell receptor therapeutics using its proprietary platform, which integrates immunopeptidomics, bead-display microfluidics, and immune synapse mapping to identify novel intracellular targets and potent TCRs directly from patient tissue.

The approach bypasses the need for T cell cloning or soluble TCR generation, enabling high-throughput target and TCR discovery across solid tumours and autoimmune indications.